Closed Loop
5
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
13 treatments under study, led by Continuous Glucose Monitoring
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (5)
Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years With Type 1 Diabetes: Impact on Quality of Life and Glycemic Control
Diabeloop for Teens
Diabeloop for Kids
Diabeloop WP7 : Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop (WP7)
Diabeloop WP6.2 : Crossover Evaluation of Glycemic Control
Research Network
Common Treatments
- Continuous Glucose Monitoring3
- Remote Monitoring Telemedicine2
- Diabeloop Software Model Predictive Control2
- External Insulin Pump2
- Dexcom G6 Continuous Glucose Monitoring1
Active Sponsors
- Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète4
- Fondation Lenval1
Top Investigators
Fondation Lenval
Necker Hospital
Related Conditions
- Diabetes Mellitus Type 14
- Young Children 6 To 12 Years Old1
- Adolescents 12 To 17 Years Old1
- Pediatric1
- Quality Of Life1